The Manufacturers Life Insurance Company Sells 102,093 Shares of GE HealthCare Technologies Inc. $GEHC

The Manufacturers Life Insurance Company reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,351,798 shares of the company’s stock after selling 102,093 shares during the period. The Manufacturers Life Insurance Company’s holdings in GE HealthCare Technologies were worth $238,581,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in GEHC. Quantinno Capital Management LP increased its holdings in shares of GE HealthCare Technologies by 25.5% in the 1st quarter. Quantinno Capital Management LP now owns 203,775 shares of the company’s stock worth $14,505,000 after purchasing an additional 41,439 shares in the last quarter. ABS Direct Equity Fund LLC bought a new position in shares of GE HealthCare Technologies during the first quarter valued at $171,000. OMERS ADMINISTRATION Corp boosted its position in shares of GE HealthCare Technologies by 53.1% during the first quarter. OMERS ADMINISTRATION Corp now owns 22,832 shares of the company’s stock valued at $1,625,000 after buying an additional 7,922 shares during the last quarter. Waverly Advisors LLC boosted its position in shares of GE HealthCare Technologies by 3.6% during the first quarter. Waverly Advisors LLC now owns 49,061 shares of the company’s stock valued at $3,492,000 after buying an additional 1,714 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new stake in GE HealthCare Technologies in the 1st quarter worth about $18,087,000. 82.06% of the stock is owned by institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CFO James Saccaro purchased 3,310 shares of the firm’s stock in a transaction on Friday, May 1st. The shares were acquired at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the transaction, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. The trade was a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Kevin Lobo purchased 10,000 shares of the firm’s stock in a transaction on Friday, May 22nd. The stock was acquired at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This trade represents a 229.20% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought 21,847 shares of company stock valued at $1,361,355 in the last quarter. Insiders own 0.36% of the company’s stock.

Analyst Ratings Changes

GEHC has been the topic of several research analyst reports. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Rothschild & Co Redburn reduced their price target on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Mizuho decreased their price objective on shares of GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Royal Bank Of Canada started coverage on shares of GE HealthCare Technologies in a research report on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 price objective on the stock. Finally, Jefferies Financial Group dropped their target price on shares of GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Ten analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and an average target price of $76.41.

GE HealthCare Technologies Trading Up 0.9%

Shares of NASDAQ:GEHC opened at $61.12 on Tuesday. The stock has a market capitalization of $27.80 billion, a price-to-earnings ratio of 14.62, a PEG ratio of 1.65 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The stock’s 50-day simple moving average is $63.63 and its two-hundred day simple moving average is $70.96. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same period in the previous year, the company earned $1.01 EPS. GE HealthCare Technologies’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s payout ratio is 3.35%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.